Financials

  • Market Capitalization 2.32 B
  • Employee 357
  • Founded 2009
  • CEO N/A
  • Website www.nurixtx.com
  • Headquarter Delaware, United States
  • FIGI BBG00SDJ8M78
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-5.54
Relación precio/flujo de caja
17.45

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1847
RXRX
Recursion Pharmaceuticals, Inc. - Class A Common Stock
4.36 USD+10.38%+4.31%+36.25%-20.73%2.33 B USD
1850
ADMA
ADMA Biologics Inc - Common Stock
10.36 USD+0.29%+7.58%+11.04%-28.85%2.32 B USD
1884
IMNM
Immunome, Inc. - Common Stock
19.55 USD+1.24%-5.96%-20.20%+40.45%2.22 B USD
1887
AUPH
Aurinia Pharmaceuticals Inc - Common Shares
16.65 USD+2.65%+5.65%+3.16%+39.56%2.22 B USD

Noticias